Author of the publication

Safety and Efficacy of the Combined Use of Ivermectin, Dexamethasone, Enoxaparin and Aspirina against COVID-19 the I.D.E.A. Protocol

, and . Journal of Clinical Trials, (2021)

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

Estudio de eficacia y seguridad para evaluar el uso de Ivermectina asociada a iota-Carragenina aplicada localmente en la cavidad bucal, en la profilaxis de la enfermedad COVID-19 en el personal de salud., , , , and . (2020)Study of the Efficacy and Safety of Topical Ivermectin + IotaCarrageenan in the Prophylaxis against COVID-19 in Health Personnel, , , and . Journal of Biomedical Research and Clinical Investigation, 2 (1): 1007 (2020)IVERMECTIN IN LONG-COVID PATIENTS, , and . Research Gate, (2021)Safety and Efficacy of the Combined Use of Ivermectin, Dexamethasone, Enoxaparin and Aspirina against COVID-19 the I.D.E.A. Protocol, and . Journal of Clinical Trials, 11 (3): 1000459 (2021)Ivermectin as Prophylaxis Against COVID-19 Retrospective Cases Evaluation, and . Microbiology and Infectious Diseases, 4 (4): 1 - 8 (2020)Safety and Efficacy of the combined use of ivermectin, dexamethasone, enoxaparin and aspirin against COVID-19, , and . (September 2020)Ivermectin and Sars Cov 2 Pandemic: the Right Time to Start as Evidenced by the Statistics of the Pandemic, and . Journal of Current Emergency Medicine Reports, 1 (1): 1-3 (2021)Usefulness of Topic Ivermectin and Carrageenan to Prevent Contagion of Covid 19 (IVERCAR). Clinical trial NCT04425850 at ClinicalTrials.gov, (2020)